LCG
DERM

Lisanti Capital Growth’s Dermira, Inc. DERM Stock Holding History

Lisanti Capital Growth’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,765
Closed -$1.02M – 125
2016
Q4 		$1.02M Buy
33,765
+6,095
+22% +$196K 1.24% 34
2016
Q3 		$936K Buy
27,670
+12,190
+79% +$393K 1.18% 38
2016
Q2 		$453K Buy
+15,480
New +$427K 0.68% 70

Other funds holding DERM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Lisanti Capital Growth's DERM Position: Q1 2017 in Review

Lisanti Capital Growth sold out of Dermira, Inc. (DERM) in Q1 2017, closing a stake of 33,765 shares — an estimated $1.02M sold.

Lisanti Capital Growth first reported a position in DERM in Q2 2016 and held it in 3 quarters. The position peaked at $1.02M in Q4 2016. 134 funds tracked by Wall St. Rank hold DERM as of Q1 2017.

  • Lisanti Capital Growth reported no remaining Dermira, Inc. position as of Q1 2017 after selling out during the quarter.
  • Lisanti Capital Growth sold 33,765 Dermira, Inc. shares in Q1 2017, an estimated $1.02M.
  • Lisanti Capital Growth first reported a position in Dermira, Inc. in Q2 2016 and held it in 3 quarters.
  • Lisanti Capital Growth's Dermira, Inc. position peaked at $1.02M in Q4 2016.
  • 134 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2017.

Based on Lisanti Capital Growth's 13F filing for Q1 2017, filed 12 May 2017.